X0306 4 2020-12-04 0 0001681682 ENDRA Life Sciences Inc. NDRA 0001691470 Michelon Francois Roger C/O ENDRA LIFE SCIENCES INC. 3600 GREEN COURT, SUITE 350 ANN ARBOR MI 48105 1 1 0 0 Chief Executive Officer Common Stock 2020-12-04 4 S 0 71519 0.83 D 92091 D These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes unvested restricted stock units. /s/ Francois R. Michelon by Mark Busch, attorney-in-fact 2020-12-08